(Date:11/26/2009)...nd. - A new generation of ultrasmall transistors a...res called semiconducting nanowires are closer to ...M, Purdue University and the University of Califor...ed how to create nanowires with layers of differen... level, which is a critical requirement for making...
(Date:11/25/2009)...TON,Fla.,Nov.25/PRNewswire/--Formanybusinesses,200...,slargestandfastestgrowingnetworkofexpertphysician...denticalhormones has grownthenumberof physicians...ans -andisinprogresstoaddmorephysician-ownedcenter..., Inthepastyear ,BodyLogicMDhasopened13newbioiden...
(Date:11/25/2009)... Nov. 25 Ardea Bioscienc...ry D. Quart, Pharm.D., president and chief executi... Annual Health Care Conference. , ,Presentation d...Health Care Conference,Date: Tuesday, Decembe...on: The New York Palace Hotel, New York, NY,Webca...
(Date:11/24/2009)... The New York investment bank KTA Capital,s clie... an AU$6.7 mil convertible note private placement ...acement was arranged by KTA Capital as Neuren,s ex... New York (PRWEB) November 23, 2009 -...ital, LLC ("KTA Capital") has announced ...
Breaking Biology Technology:Nanowires key to future transistors, electronics 2Nanowires key to future transistors, electronics 3Nation's Largest Network of Doctors Specializing in Bioidentical Hormones Grows at an Exponential Rate 2Nation's Largest Network of Doctors Specializing in Bioidentical Hormones Grows at an Exponential Rate 3Ardea Biosciences to Present at the Piper Jaffray 21st Annual Health Care Conference 2KTA Capital Arranges an AU$6.7 Million Private Placement by Neuren Pharmaceuticals 2...ofitable with more than $500 million in ...ebcast Monday, November 10, 8:30 a.m. EST at ...LSBAD, Calif., Nov. 10 Isis,Pharmaceuticals, Inc....sults,for the third quarter ended September 30, 20...rs of 2008 and 2007 was $3.2 million and $20.0 mil...
...sset, Inc.,(Nasdaq: VRUS ) announces management w...Global Investment Conference and the Lazard Capita...onferences will be held in New York,NY., Schaefer... Officer,will provide an overview of the company a...vember 11, 2008 at 12:25 PM (ET) and at the Lazard...
...6 Million in 3Q08 -- -- 3Q08 Net Income I...uted EPS $0.21 versus 3Q07 Diluted EPS $0.16 --, ... American Oriental,Bioengineering, Inc. (NYSE: AO...ng health through the development, manufacture and...n and over the counter ("OTC") products in,China, ...
Other Biology Technology:Isis Reports Financial Results and Highlights for Third Quarter of 2008 2Isis Reports Financial Results and Highlights for Third Quarter of 2008 3Isis Reports Financial Results and Highlights for Third Quarter of 2008 4Isis Reports Financial Results and Highlights for Third Quarter of 2008 5Isis Reports Financial Results and Highlights for Third Quarter of 2008 6Isis Reports Financial Results and Highlights for Third Quarter of 2008 7Isis Reports Financial Results and Highlights for Third Quarter of 2008 8Isis Reports Financial Results and Highlights for Third Quarter of 2008 9Isis Reports Financial Results and Highlights for Third Quarter of 2008 10Isis Reports Financial Results and Highlights for Third Quarter of 2008 11Isis Reports Financial Results and Highlights for Third Quarter of 2008 12Isis Reports Financial Results and Highlights for Third Quarter of 2008 13Isis Reports Financial Results and Highlights for Third Quarter of 2008 14Isis Reports Financial Results and Highlights for Third Quarter of 2008 15Pharmasset to Present at Two Upcoming Investor Conferences 2Pharmasset to Present at Two Upcoming Investor Conferences 3American Oriental Bioengineering Reports Third Quarter 2008 Financial Results 2American Oriental Bioengineering Reports Third Quarter 2008 Financial Results 3American Oriental Bioengineering Reports Third Quarter 2008 Financial Results 4American Oriental Bioengineering Reports Third Quarter 2008 Financial Results 5American Oriental Bioengineering Reports Third Quarter 2008 Financial Results 6American Oriental Bioengineering Reports Third Quarter 2008 Financial Results 7American Oriental Bioengineering Reports Third Quarter 2008 Financial Results 8Mouse Anti-Mouse BKBeta2 potassium channel Monoclonal Antibody, Unconjugated, Clone N53/32 from UC Davis/NINDS/NIMH NeuroMab Facility
... inhibitor (IC50 = 59.2 M). Formula: C 29 H... RT CAS: 33419-42-0 Solubility: Soluble ...aalpha,9beta(R*)]]-9-[(4,6-O-Ethylidene-beta-D-glu...3,5-dimethoxyphenyl)-furo[3',4':6,7]naphtho[2,3-d]...
Rabbit Anti-Human ALS2CR2 Polyclonal Antibody, Unconjugated from Proteintech Group, Inc.
Rabbit Anti-IKKbeta / IKK-2 Polyclonal Antibody, Unconjugated from BioVision
Biology Products: